Reply: budesonide.

Reply: budesonide.

Bibliographic Details
Main Authors:	Sandborn, W, Travis, S, Ballard, D
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Reply
by: Sandborn, W, et al.
Published: (2013)

Budesonide MMX® for the induction of remission of mild to moderate ulcerative colitis: a pooled safety analysis.
by: Lichtenstein, G, et al.
Published: (2015)

Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study.
by: Sandborn, W, et al.
Published: (2012)

Induction of Clinical and Endoscopic Remission of Mild to Moderately Active Ulcerative Colitis With Budesonide MMX (R) 9 mg: Analysis of Pooled Data from Two Phase 3 Studies
by: Sandborn, W, et al.
Published: (2011)

High-dose budesonide for early COVID-19 - Authors' reply
by: Hobbs, FDR, et al.
Published: (2021)

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study.
by: Travis, S, et al.
Published: (2014)

Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies.
by: Sandborn, W, et al.
Published: (2015)

Budesonide and fluticasone and adrenal suppression
by: Mona A Fouda, et al.
Published: (2012-01-01)

Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, <i>12</i>, 211”
by: Antonella Casiraghi, et al.
Published: (2020-08-01)

BUDESONIDE TREATMENT IN CHILDREN PRESCHOOL AGE
by: E.A. Vishneva, et al.
Published: (2010-01-01)

BUDESONIDE TREATMENT IN CHILDREN PRESCHOOL AGE
by: E.A. Vishneva, et al.
Published: (2010-01-01)

Budesonide in patients with obstructive pulmonary disease
by: N. N. Mescheryakova
Published: (2015-12-01)

New Strategies for Improving Budesonide Skin Retention
by: Cristina Padula, et al.
Published: (2021-12-01)

Effect of different courses of Budesonide on endoscopic dacryocystorhinostomy
by: Zhi-Wei Qi, et al.
Published: (2023-07-01)

Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis
by: Antonella Casiraghi, et al.
Published: (2020-03-01)

The specific use of budesonide in the treatment of allergic rhinitis
by: S. V. Tsarev
Published: (2016-12-01)

Controlled trial of budesonide–formoterol as needed for mild asthma
by: Beasley, R, et al.
Published: (2019)

Diagnosing and Treating IgAN: Steroids, Budesonide, or Maybe Both?
by: Christodoulos Keskinis, et al.
Published: (2024-02-01)

Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge.
by: Wong, C, et al.
Published: (1994)

Thermodynamic and Structural Study of Budesonide—Exogenous Lung Surfactant System
by: Atoosa Keshavarzi, et al.
Published: (2024-03-01)

Antiviral Effect of Budesonide against SARS-CoV-2
by: Natalie Heinen, et al.
Published: (2021-07-01)

Evaluating the effects of processing parameters on budesonide nanocrystals prepared by nanomilling
by: Rebecca Olubi, et al.
Published: (2022-11-01)

Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge
by: Wong, C, et al.
Published: (1994)

Some aspects of application of the combination of formoterol and budesonide: what is changed?
by: A. A. Vizel, et al.
Published: (2019-12-01)

Reply
by: Wang, X, et al.
Published: (2011)

Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control.
by: Barnes, N, et al.
Published: (2007)

Maintenance of Crohn's disease over 12 months: fixed versus flexible dosing regimen using budesonide controlled ileal release capsules.
by: Green, JR, et al.
Published: (2001)

Pegylated Phospholipid Nanomicelles Containing Budesonide Or Beclimethasone Dipropionate For Pulmonary Delivery
by: Sahib, Mohanad Naji
Published: (2011)

Clinical efficacy of budesonide combined with acetylcysteine in the treatment of mycoplasma pneumonia infection
by: Jing Chen, et al.
Published: (2023-11-01)

The Long-Term Effects of Budesonide Nasal Irrigation in Chronic Rhinosinusitis with Asthma
by: Seon Min Jung, et al.
Published: (2022-05-01)

β-Cyclodextrin Inclusion Complexes of Budesonide with Enhanced Bioavailability for COPD Treatment
by: Georgia Michailidou, et al.
Published: (2021-12-01)

Budesonide, an anti-inflammatory drug, exacerbate clostridioides difficile colitis in mice
by: Qianyun Lin, et al.
Published: (2023-11-01)

Meta-analysis of dose selection for budesonide in the treatment of Chinese patients with AECOPD
by: Mengsha Qi, et al.
Published: (2021-12-01)

Targeted-release budesonide in immunoglobulin A nephropathy; a mini-review
by: Shiva Toumaj, et al.
Published: (2023-06-01)

The Effect of Budesonide that is the Topical Corticosteroid on the Rat Nasal Mucosa (Experimental Study)
by: Atila Güngör, et al.
Published: (2002-03-01)

Surfactant-Assisted Distal Pulmonary Distribution of Budesonide Revealed by Mass Spectrometry Imaging
by: Riccardo Zecchi, et al.
Published: (2021-06-01)

Formulation of Budesonide-Loaded Polymeric Nanoparticles into Hydrogels for Local Therapy of Atopic Dermatitis
by: Marta Slavkova, et al.
Published: (2024-01-01)

Introducing vedolizumab to clinical practice: who, when and how?
by: Bryant, R, et al.
Published: (2015)

In vitro/in vivo evaluation of procera gum-ethylcellulose microspheres for colonic delivery of budesonide.
by: Lalduhsanga Pachuau, et al.
Published: (2016-10-01)

Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice
by: Shiyun Xian, et al.
Published: (2023-12-01)